Senyalització Oncogènica i del Desenvolupament

Publicacions (129)

Cercador de publicacions

Santacana M; Maiques O; Valls J; Gatius S; Abó AI; López-García MÁ; Mota A; Reventós J; Moreno-Bueno G; Palacios J; Bartosch C; Dolcet X; Matias-Guiu X

A 9-protein biomarker molecular signature for predicting histologic type in endometrial carcinoma by immunohistochemistry

HUMAN PATHOLOGY 45 2394-2403. .

[doi:10.1016/j.humpath.2014.06.031]

Alonso-Alconada L; Eritja N; Muinelo-Romay L; Barbazan J; Lopez-Lopez R; Matias-Guiu X; Gil-Moreno A; Dolcet X; Abal M

ETV5 transcription program links BDNF and promotion of EMT at invasive front of endometrial carcinomas

CARCINOGENESIS 35 2679-2686. .

[doi:10.1093/carcin/bgu198]

Alonso-Alconada, Lorena; Muinelo-Romay, Laura; Madissoo, Kadri; Diaz-Lopez, Antonio; Krakstad, Camilla; Trovik, Jone; Wik, Elisabeth; Hapangama, Dharani; Coenegrachts, Lieve; Cano, Amparo; Gil-Moreno, Antonio; Chiva, Luis; Cueva, Juan; Vieito, Maria; Ortega, Eugenia; Mariscal, Javier; Colas, Eva; Castellvi, Josep; Cusido, Maite; Dolcet, Xavier; Nijman, Hans W.; Bosse, Tjalling; Green, John A.; Romano, Andrea; Reventos, Jaume; Lopez-Lopez, Rafael; Salvesen, Helga B.; Amant, Frederic; Matias-Guiu, Xavier; Moreno-Bueno, Gema; Abal, Miguel; ENITEC Consortium

Molecular profiling of circulating tumor cells links plasticity to the metastatic process in endometrial cancer

Molecular Cancer 13 -. .

[doi:10.1186/1476-4598-13-223]

Maiques, O.; Cuevas, D.; García Dios, D.A.; Coenegrachts, L.; Santacana, M.; Velasco, A.; Romero, M.; Gatius, S.; Lambrechts, D.; Müller, S.; Pedersen, H.C.; Dolcet, X.; Amant, F.; Matias-Guiu, X.

FISH analysis of PTEN in endometrial carcinoma. Comparison with SNP arrays and MLPA

Histopathology 65 371-388. .

[doi:10.1111/his.12396]

Bergadà L; Pallares J; Arcidiacono MV; Cardus A; Santacana M; Valls J; Cao G; Fernàndez E; Dolcet X; Dusso AS; Matias-Guiu X

Role of local bioactivation of vitamin D by CYP27A1 and CYP2R1 in the control of cell growth in normal endometrium and endometrial carcinoma

LABORATORY INVESTIGATION 94 608-622. .

[doi:10.1038/labinvest.2014.57]

Eritja N; Domingo M; Dosil MA; Mirantes C; Santacana M; Valls J; Llombart-Cussac A; Matias-Guiu X; Dolcet X

Combinatorial Therapy Using Dovitinib and ICI182.780 (Fulvestrant) Blocks Tumoral Activity of Endometrial Cancer Cells

MOLECULAR CANCER THERAPEUTICS 13 776-787. .

[doi:10.1158/1535-7163.MCT-13-0794]

Bergadà L; Yeramian A; Sorolla A; Matias-Guiu X; Dolcet X

Antioxidants Impair Anti-Tumoral Effects of Vorinostat, but Not Anti-Neoplastic Effects of Vorinostat and Caspase-8 Downregulation

PLoS One 9 -. .

[doi:10.1371/journal.pone.0092764]

Leyva-Díaz E; del Toro D; Menal MJ; Cambray S; Susín R; Tessier-Lavigne M; Klein R; Egea J; López-Bendito G

FLRT3 Is a Robo1-Interacting Protein that Determines Netrin-1 Attraction in Developing Axons

CURRENT BIOLOGY 24 494-508. .

[doi:10.1016/j.cub.2014.01.042]

Maiques O; Santacana M; Valls J; Pallares J; Mirantes C; Gatius S; García Dios DA; Amant F; Pedersen HC; Dolcet X; Matias-Guiu X

Optimal protocol for PTEN immunostaining; role of analytical and preanalyticat variables in PTEN staining in normal and neoplastic endometrial, breast, and prostatic tissues

HUMAN PATHOLOGY 45 522-532. .

[doi:10.1016/j.humpath.2013.10.018]

Bergada, L; Santacana, M; Garcia, V; Carceller, JA; Dolcet, X; Matias-Guiu, X

Role of Y-H2AX Expression in Prediction of Radiation Resistance in Endometrial Carcinoma

LABORATORY INVESTIGATION 94 276-276. .

Santacana, M; Maiques, O; Valls, J; Gatius, S; Lopez-Garcia, MA; Palacios, J; Dolcet, X; Matias-Guiu, X

Immunohistochemical Profiling in Assessing Histological Type in Endometrial Carcinoma

MODERN PATHOLOGY 27 304-304. .

Macià A; Vaquero M; Gou-Fàbregas M; Castelblanco E; Valdivielso JM; Anerillas C; Mauricio D; Matias-Guiu X; Ribera J; Encinas M

Sprouty1 induces a senescence-associated secretory phenotype by regulating NFjB activity: implications for tumorigenesis

CELL DEATH AND DIFFERENTIATION 21 333-343. .

[doi:10.1038/cdd.2013.161]